Skip to main content

Table 10 Comparison of PPV between PSA (> 4ng/dL) and cut-points 1–4 by analysis method

From: Improving prostate cancer detection in veterans through the development of a clinical decision rule for prostate biopsy

 

Method 1

Method 2

Crude PPV

 44.7 %

 20.6 %

Cut-point 1

 61.8 %

 55.3 %

Cut-point 2

 47.1 %

 20.6%

Cut-point 3

 50.9 %

 28.7%

Cut-point 4

 63.4 %

 36.7%